Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT07493265

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Led by Eisai Inc. · Updated on 2026-05-14

64

Participants Needed

57

Research Sites

48 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of excessive daytime sleepiness (EDS) as assessed by Mean Sleep Latency (MSL) (measured from the first 4 maintenance of wakefulness tests \[MWTs\]).

CONDITIONS

Official Title

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female, age 18 years or older at time of consent
  • For NT1 cohort: Diagnosis of narcolepsy type 1 within last 10 years confirmed by PSG and MSLT or cerebrospinal fluid orexin-A/hypocretin-1 ≤110 pg/mL
  • For NT1 cohort: At least 4 episodes of cataplexy per week averaged over 2 weeks confirmed by diary
  • For NT2 cohort: Diagnosis of narcolepsy type 2 within last 10 years confirmed by PSG and MSLT
  • Epworth Sleepiness Scale (ESS) score of 10 or higher
  • Regular bedtime between 22:00 and 01:00 based on screening diary
  • Regular wake time between 05:00 and 10:00 based on screening diary
  • Reports being in bed 7 to 9 hours per night based on sleep diary
  • Diary completion compliance rate at least 80% during screening
  • Body mass index (BMI) between 18 and less than 35 kg/m² at screening
Not Eligible

You will not qualify if you...

  • Females who are pregnant or breastfeeding at screening or baseline
  • Females of childbearing potential not using or agreeing to use highly effective contraception before and during the study and for 28 days after
  • Clinically significant illness or infection requiring treatment within 8 or 4 weeks before dosing
  • Diseases affecting study outcome such as psychiatric, gastrointestinal, liver, kidney, respiratory, endocrine, hematological, neurological, or cardiovascular disorders
  • History of surgery affecting drug metabolism or congenital metabolic abnormalities
  • Severe organ impairment or abnormal clinical findings requiring treatment at screening or baseline
  • Prolonged QTc interval over 450 ms at screening or baseline
  • Persistent abnormal blood pressure or heart rate outside specified limits
  • Lifetime history of suicidal behavior or recent unstable psychiatric disorders
  • Hypersensitivity to study drug or excipients
  • Use of St. John's Wort within 5 times the drug half-life before dosing
  • Medical conditions compromising safe study completion
  • Planned surgeries requiring general, spinal, or epidural anesthesia during the study
  • Known HIV positive status
  • Acute Epstein Barr virus infection at baseline
  • Active hepatitis B or C infection within 6 months before dosing
  • Recent changes in statin therapy within 6 months before dosing
  • Moderate to severe obstructive sleep apnea or current use of related therapies
  • Symptomatic restless legs syndrome
  • Apnea-hypopnea index of 15 or higher on screening PSG
  • Use of anticataplectic, psychostimulant, or sedative medications within 5 times the drug half-life before screening until after follow-up
  • Inability to discontinue strong or moderate CYP3A inhibitors or inducers before dosing until after follow-up
  • History of drug or alcohol dependency or positive drug/alcohol test at screening or baseline
  • Refusal to abstain from recreational drugs during the study
  • Current participation in another clinical study or recent use of investigational drugs
  • Recent blood product receipt or blood/plasma donation
  • Past participation in orexin agonist studies with adverse reactions or inefficacy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 57 locations

1

SDS Clinical Trials, Inc-California-Santa Ana

Santa Ana, California, United States, 92705

Not Yet Recruiting

2

Meris Clinical Research-310 Oakfield Dr

Brandon, Florida, United States, 33511

Not Yet Recruiting

3

Hope Research Network Trials -6500 NW 77th CT

Medley, Florida, United States, 33166

Not Yet Recruiting

4

Vitaly Clinical Research LLC

Miami, Florida, United States, 33125

Not Yet Recruiting

5

Anchor Medical Research LLC

Miami, Florida, United States, 33176

Not Yet Recruiting

6

New Access Research & Medical Services Inc - Kendall

Miami, Florida, United States, 33186

Not Yet Recruiting

7

NeuroTrials Research, Inc

Atlanta, Georgia, United States, 30328

Not Yet Recruiting

8

Sleep Practitioners, LLC

Macon, Georgia, United States, 31210

Not Yet Recruiting

9

Clinical Research Institute Stockbridge

Stockbridge, Georgia, United States, 30291

Not Yet Recruiting

10

Wu Lab at Johns Hopkins University

Baltimore, Maryland, United States, 21205

Not Yet Recruiting

11

Midwest Center for Sleep Disorders (MWCSD)

Lansing, Michigan, United States, 48911

Not Yet Recruiting

12

Henry Ford Medical Center - Columbus

Novi, Michigan, United States, 48377

Not Yet Recruiting

13

Revive Research Institute - Southfield - 23999 Northwestern Hwy

Southfield, Michigan, United States, 48075

Not Yet Recruiting

14

Research Carolina Elite

Denver, North Carolina, United States, 28037

Not Yet Recruiting

15

Bogan Sleep Consultants, LLC

Columbia, South Carolina, United States, 29201

Actively Recruiting

16

Future Search Trials of Neurology

Austin, Texas, United States, 78731

Not Yet Recruiting

17

Sleep Therapy and Research Center

San Antonio, Texas, United States, 78229

Not Yet Recruiting

18

ANIMA Research Center

Alken, Belgium, 3570

Not Yet Recruiting

19

UZ Gent

Ghent, Belgium, 9000

Not Yet Recruiting

20

CaRe Clinic - Calgary - HyperCore - PPDS

Calgary, Alberta, Canada, T2N 4L7

Not Yet Recruiting

21

AMNDX, Inc

Markham, Ontario, Canada, L3R1A3

Not Yet Recruiting

22

West Ottawa Sleep Center

Ottawa, Ontario, Canada, K2C 0P7

Not Yet Recruiting

23

Centricity Research - CPU - Bayview

Toronto, Ontario, Canada, M4P 1P2

Not Yet Recruiting

24

Sleep & Alertness Clinic

Toronto, Ontario, Canada, M5S 3A5

Not Yet Recruiting

25

Xuanwu Hospital Capital Medical University

Beijing, Beijing Municipality, China, 100053

Not Yet Recruiting

26

The First Hospital of Jilin University

Changchun, Changchun, China, 130021

Not Yet Recruiting

27

Nanfang Hospital Southern Medical University

Guangdong, Guangdong, China, 510515

Not Yet Recruiting

28

The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital)

Guangzhou, Guangzhou, China, 510630

Not Yet Recruiting

29

Shandong Provincial Qianfoshan Hospital

Jinan, Jinan, China, 250013

Not Yet Recruiting

30

The Second Affiliated Hospital of Nanchang University - Donghu Campus

Nanchang, Nanchang, China, 330006

Not Yet Recruiting

31

Huashan Hospital Fudan University

Shanghai, Shanghai Municipality, China, 200040

Not Yet Recruiting

32

Henan Provincial People's Hospital

Zhengzhou, Zhengzhou, China, 450003

Not Yet Recruiting

33

LMU Klinikum der Universität München - Campus Grosshadern

Bayern, Muenchen, Germany, 81377

Not Yet Recruiting

34

Alexianer St. Hedwig Kliniken Berlin GmbH

Berlin, Germany, 10115

Not Yet Recruiting

35

Advanced Sleep Research GmbH

Berlin, Germany, 10117

Not Yet Recruiting

36

Universitätsklinikum Gießen und Marburg GmbH - Standort Marburg

Marburg, Germany, 35043

Not Yet Recruiting

37

Somni Bene Institut für Medizinische Forschung und Schlafmedizin Schwerin GmbH

Schwerin, Germany, 19053

Not Yet Recruiting

38

IRCCS Istituto dell Scienze Neurologiche di Bologna

Bologna, Italy, 40139

Not Yet Recruiting

39

Fondazione Istituto Neurologico Nazionale Casimiro Mondino IRCCS

Pavia, Italy, 27100

Not Yet Recruiting

40

Centro Ricerche Cliniche Di Verona

Verona, Italy, 37134

Not Yet Recruiting

41

The Kei-Ai Corporation Aggregate Sapporo Hanazono Hospital

Sapporo, Hokkaido, Japan, 064-0915

Actively Recruiting

42

RESM Respiratory and Sleep Medical Care Clinic

Yokohama, Kanagawa, Japan, 222-0033

Not Yet Recruiting

43

Howakai Kuwamizu Hospital

Kumamuto-shi, Kumamuto, Japan, 862-0954

Not Yet Recruiting

44

Gokeikai Osaka Kaisei Hospital

Oskaka, Osaka, Japan, 532-0003

Not Yet Recruiting

45

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea, 13620

Not Yet Recruiting

46

Keimyung University Dongsan Hospital

Daegu, South Korea, 42601

Not Yet Recruiting

47

Severance Hospital Yonsei University Health System

Seoul, South Korea, 03722

Not Yet Recruiting

48

The Catholic University of Korea, St. Vincent's Hospital

Suwon, South Korea, 16247

Not Yet Recruiting

49

Hospital Universitario de La Ribera

Alzira, Spain, 46600

Not Yet Recruiting

50

Corporacio Sanitaria Parc Tauli

Barcelona, Spain, 08208

Not Yet Recruiting

51

Hospital Universitario de Donostia

Donostia / San Sebastian, Spain, 20014

Not Yet Recruiting

52

Hospital Ruber Internacional

Madrid, Spain, 28034

Not Yet Recruiting

53

Hospital Universitario Fundacion Jimenez Diaz

Madrid, Spain, 28040

Not Yet Recruiting

54

Hospital Blua Sanitas Valdebebas

Madrid, Spain, 28055

Not Yet Recruiting

55

Hospital HM Puerta del Sur

Móstoles, Spain, 28936

Not Yet Recruiting

56

Hospital Universitario Virgen Macarena

Seville, Spain, 41009

Not Yet Recruiting

57

Inselspital - Universitätsspital Bern

Bern, Switzerland, 3010

Not Yet Recruiting

Loading map...

Research Team

E

Eisai Medical Information

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here